FDA Panel Backs Amgen Skin Drug for Use in Kids

HealthDay News -- A U.S. Food and Drug Administration advisory panel recommended Wednesday that the psoriasis drug Enbrel be approved for use in children who have moderate-to-severe forms of the skin disease.

MORE ON THIS TOPIC